A group of oncology experts discusses the adjuvant treatment of melanoma, providing expert insights into the management of immunotherapy-related endocrine and cardiac toxicities, with a case discussion to emphasize these important topics.
February 9th 2024
Javid Moslehi, MD, presents Case 2, highlighting a 63-year-old female patient with metastatic melanoma on dual immunotherapy, illustrating treatment-related myocarditis and emphasizing key aspects of immunotherapy-induced cardiac toxicities.
Javid Moslehi, MD, shares expert perspectives on the diagnosis and management of immunotherapy-related myocarditis.
February 16th 2024
Javid Moslehi, MD provides expert insights into baseline and surveillance cardiac testing for individuals receiving immunotherapy.
A panel of oncology experts explore the challenges in treating patients with immunotherapy-related toxicities using corticosteroids.
A group of oncology experts provide forward-looking perspectives and clinical insights in the treatment of melanoma.